These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33942600)

  • 1. Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target.
    Cesaro A; Riccio C; Calabrò P
    Monaldi Arch Chest Dis; 2021 May; 91(2):. PubMed ID: 33942600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severely frail elderly patients do not need lipid-lowering drugs.
    Mallery LH; Moorhouse P; McLean Veysey P; Allen M; Fleming I
    Cleve Clin J Med; 2017 Feb; 84(2):131-142. PubMed ID: 28198686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.
    Vogt L; Laverman GD; Dullaart RP; Navis G
    Nephrol Dial Transplant; 2004 Jan; 19(1):5-8. PubMed ID: 14671028
    [No Abstract]   [Full Text] [Related]  

  • 5. PCSK9 inhibitors- A new age in lipid management?
    Grant PJ
    Diab Vasc Dis Res; 2017 May; 14(3):171. PubMed ID: 28467196
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
    Rabar S; Harker M; O'Flynn N; Wierzbicki AS;
    BMJ; 2014 Jul; 349():g4356. PubMed ID: 25035388
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia: Drugs for Cardiovascular Risk Reduction in Adults.
    Last AR; Ference JD; Menzel ER
    Am Fam Physician; 2017 Jan; 95(2):78-87. PubMed ID: 28084704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis. ISPD guidelines/recommendations. International Society for Peritoneal Dialysis.
    Fried L; Hutchison A; Stegmayr B; Prichard S; Bargman JM
    Perit Dial Int; 1999; 19(1):7-16. PubMed ID: 10201335
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin utilization patterns for the primary prevention of cardiovascular events: a retrospective study in patients with diabetes mellitus in Hong Kong.
    Lee VW; Ho IC; Chan WS; Tam KY; Lee KK
    Am J Cardiovasc Drugs; 2008; 8(3):199-205. PubMed ID: 18533740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.
    Wilkins JT; Lloyd-Jones DM
    JAMA; 2021 Jul; 326(3):266-267. PubMed ID: 34283191
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.
    Farahani P; Levine M; Gaebel K; LeLorier J; Perrault S; Gillis J; Soon J
    Clin Invest Med; 2007; 30(2):E63-9. PubMed ID: 17716543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin therapy in primary CVD prevention remains a hot-button topic for some.
    Mitka M
    JAMA; 2011 Nov; 306(19):2077-8. PubMed ID: 22089707
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations of the second Indo-U.S. health summit on prevention and control of cardiovascular disease among Asian Indians.
    Enas EA; Singh V; Munjal YP; Gupta R; Patel KC; Bhandari S; Agarwal AK; Joshi SR; Anoop M; Prabhakaran D; Shah B; Reddy S; Sharma B; Trehan N; Yavagal ST; Kasliwal RR;
    Indian Heart J; 2009; 61(3):265-74. PubMed ID: 20503833
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological management of dyslipidemia in high and very high cardiovascular risk patients.
    Pascual Fuster V
    Rev Esp Sanid Penit; 2016 Dec; 18(3):95-108. PubMed ID: 27831597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive cardiovascular recommendations].
    Maiques Galán A; Villar Alvarez F; Brotons Cuixart C; Torcal Laguna J; Orozco-Beltrán D; Navarro Pérez J; Lobos-Bejarano JM; Banegas Banegas JR; Ortega Sánchez-Pinilla R; Gil Guillén V; Solana Saura P;
    Aten Primaria; 2007 Nov; 39 Suppl 3():15-26. PubMed ID: 19288694
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in Oral Lipid-lowering Therapy: Position Document of the Spanish Society of Cardiology.
    Anguita Sánchez M; Castro Conde A; Cordero Fort A; García-Moll Marimón X; Gómez Doblas JJ; González-Juanatey JR; Lidón Corbi RM; López-Sendón JL; Mostaza Prieto J; Rodríguez Padial L
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1083-1087. PubMed ID: 27650859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering therapy in patients with peripheral arterial disease.
    Daskalopoulou SS; Athyros VG; Hamilton G; Mikhailidis DP
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10(2):145-7. PubMed ID: 15965566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.